Yup heart surgery is probably completely and utterly out of reach of the majority of the population. Market size? Maybe a rough guide would be to apply the incidence/prevalence of CHD in the population that has private health insurance (going by the above link, thats about 5% of the population or 66 million have private health insurance).
Using the figures used by other posters:
Number of private health insured = 66 million
Population growth = 2% x 66 million = 1.3 million p.a.
Incidence of CHD = 1% x 1.3 million = 13,200 p.a.
Number of operations = 25% x 13,200 = 3,300 p.a.
The country in itself wont be a company maker but its another market to add to the list and for sure over time a progressively larger segment of the population in India will join the ranks of those that can afford proper healthcare.
- Forums
- ASX - By Stock
- AVR
- Ann: Regulatory approval to launch CardioCel in India
Ann: Regulatory approval to launch CardioCel in India, page-64
-
- There are more pages in this discussion • 6 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
|
|||||
Last
$15.25 |
Change
-0.250(1.61%) |
Mkt cap ! $322.3M |
Open | High | Low | Value | Volume |
$15.50 | $15.50 | $14.80 | $140.4K | 9.315K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 297 | $15.00 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$15.25 | 1300 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 60 | 14.800 |
1 | 206 | 14.500 |
1 | 1388 | 14.400 |
1 | 60 | 14.350 |
1 | 38 | 14.260 |
Price($) | Vol. | No. |
---|---|---|
15.250 | 1300 | 2 |
15.400 | 238 | 1 |
15.500 | 370 | 1 |
15.660 | 1925 | 2 |
15.950 | 848 | 2 |
Last trade - 16.10pm 23/08/2024 (20 minute delay) ? |
AVR (ASX) Chart |
The Watchlist
SER
STRATEGIC ENERGY RESOURCES LIMITED
David DeTata, Managing Director
David DeTata
Managing Director
SPONSORED BY The Market Online